Altamira Therapeutics Gets Nasdaq Noncompliance Notice; Shares Fall After Hours

MT Newswires Live10-05

Altamira Therapeutics (CYTO) said Friday it was notified by the Nasdaq Stock Market that it is not in compliance with a listing rule requiring securities to have a minimum bid price of $1 per share.

The bid price for the company's stocks fell below $1.00 per share for the last 30 business days, spanning from Aug. 16 to Sept. 27, according to the company.

Altamira isn't eligible for a cure period because the company did one or more reverse stock splits over the previous two-year period with a cumulative ratio of 250 shares or more to one, the company said, adding it will appeal this decision to a hearing panel.

There's no assurance that the panel will accept Altamira's request for continued listing or that it will grant any extension, the company added.

Altamira shares were falling past 9% in after-hours activity.

Price: 0.5985, Change: -0.06, Percent Change: -9.22

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2473699201?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-05 04:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2473699201","market":"sg","top_or_hot":-1,"title":"Altamira Therapeutics Gets Nasdaq Noncompliance Notice; Shares Fall After Hours","media":"MT Newswires Live","content":"<html><body><p> Altamira <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (CYTO) said Friday it was notified by the Nasdaq Stock Market that it is not in compliance with a listing rule requiring securities to have a minimum bid price of $1 per share.</p><p>The bid price for the company's stocks fell below $1.00 per share for the last 30 business days, spanning from Aug. 16 to Sept. 27, according to the company.</p><p>Altamira isn't eligible for a cure period because the company did one or more reverse stock splits over the previous two-year period with a cumulative ratio of 250 shares or more to one, the company said, adding it will appeal this decision to a hearing panel.</p><p>There's no assurance that the panel will accept Altamira's request for continued listing or that it will grant any extension, the company added.</p><p>Altamira shares were falling past 9% in after-hours activity.</p><p>Price: 0.5985, Change: -0.06, Percent Change: -9.22</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Altamira Therapeutics Gets Nasdaq Noncompliance Notice; Shares Fall After Hours</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAltamira Therapeutics Gets Nasdaq Noncompliance Notice; Shares Fall After Hours\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-05 04:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Altamira Therapeutics (CYTO) said Friday it was notified by the Nasdaq Stock Market that it is not in compliance with a listing rule requiring securities to have a minimum bid price of $1 per share....</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":".IXIC","symbol_name":"NASDAQ Composite","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2473699201","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2473699201","pubTimestamp":1728073759,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Altamira Therapeutics  said Friday it was notified by the Nasdaq Stock Market that it is not in compliance with a listing rule requiring securities to have a minimum bid price of $1 per share.The bid price for the company's stocks fell below $1.00 per share for the last 30 business days, spanning from Aug. 16 to Sept. 27, according to the company.Altamira isn't eligible for a cure period because the company did one or more reverse stock splits over the previous two-year period with a cumulative ratio of 250 shares or more to one, the company said, adding it will appeal this decision to a hearing panel.There's no assurance that the panel will accept Altamira's request for continued listing or that it will grant any extension, the company added.Altamira shares were falling past 9% in after-hours activity.Price: 0.5985, Change: -0.06, Percent Change: -9.22","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{".IXIC":"NASDAQ Composite","LENZ":"Therapeutics","QID":"纳指两倍做空ETF","BK4585":"ETF&股票定投概念","BK4139":"生物科技","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","BK4007":"制药","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","SQQQ":"纳指三倍做空ETF","BK4588":"碎股","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","QLD":"纳指两倍做多ETF","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","CYTO":"Altamira Therapeutics Ltd.","PSQ":"纳指反向ETF","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","NDAQ":"纳斯达克OMX交易所","TQQQ":"纳指三倍做多ETF","BK4112":"金融交易所和数据"},"translate_title":"Altamira Therapeutics收到纳斯达克不合规通知；盘后股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":1,"NQmain":1,".IXIC":1,"LENZ":1,"CYTO":0.9,"TQQQ":0.6,"SQQQ":0.6,"QLD":0.6,"QID":0.6,"PSQ":0.6,"MNQmain":0.6},"content_text":"Altamira Therapeutics (CYTO) said Friday it was notified by the Nasdaq Stock Market that it is not in compliance with a listing rule requiring securities to have a minimum bid price of $1 per share.The bid price for the company's stocks fell below $1.00 per share for the last 30 business days, spanning from Aug. 16 to Sept. 27, according to the company.Altamira isn't eligible for a cure period because the company did one or more reverse stock splits over the previous two-year period with a cumulative ratio of 250 shares or more to one, the company said, adding it will appeal this decision to a hearing panel.There's no assurance that the panel will accept Altamira's request for continued listing or that it will grant any extension, the company added.Altamira shares were falling past 9% in after-hours activity.Price: 0.5985, Change: -0.06, Percent Change: -9.22","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2473699201"}